The<unk>  was established by Susan G.<unk>  for the Cure in 1992 to recognize leading scientists for their significant work in advancing research concepts or clinical application in the fields of breast cancer research, screening or treatment.
The intent of the<unk>  is to recognize scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer. The<unk> ees are nominated and selected by a panel of their peers. Recipients are also invited to present their work in a lecture at the annual San Antonio Breast Cancer Symposium (SABCS).
Past recipients of the<unk>  include V. Craig Jordan, Ph.D., OBE a pioneer in the use of tamoxifen; Dr. Mary-Claire King, Ph.D., whose research isolated the BRCA1 and BRCA2 gene mutations associated with genetic forms of breast cancer; Larry Norton, M.D., whose dose-density approach to the administration of chemotherapy has revolutionized breast cancer treatment; Dr. Anita Roberts, who co-discovered the TGF-beta molecule; and Leland Hartwell, Ph.D., winner of the 2001 Nobel Prize for medicine or physiology who was recognized for his achievements in the understanding the cell cycle in the development of cancer.<unk><unk>  recipients each receive a $20,000 honorarium and a special citation of this<unk> .
Komen Brinker Award for Scientific Distinction
Edit summary
Reward system
Scientific consensus
Standard for the Uniform Scheduling of Drugs and Poisons
Overview template
Microchapters project
Chain of survival